Individual InvestorsEmployee Shareholders Institutional InvestorsPrivate Companies Accredited InvestorsSeed & Angel InvestorsAsset Managers & Hedge FundsFamily OfficesVenture Capital FirmsWealth Managers & RIAsWho We Serve Trading Data Liquidity Programs Retirement Individual InvestingForge MarketplaceFind new private company investment opportunities​Browse CompaniesInstitutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Forge PriceA proprietary indicative price, calculated daily, for approximately 200 pre-IPO companiesForge DataAnalyze private markets via Forge’s intuitive web application​Forge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Liquidity ProgramsRetain and reward employees with company-sponsored liquidity solutions like tender offers and customized programsSelf-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRAWhat We Do All insights Reports and highlights News and trends Private market education Tips and tutorials Forge Investment OutlookPrivate Market UpdatesIPO calendarPrivate Magnificent 7Emerging trendsPrivate company newsUpcoming IPOsAll guidesPrivate market basicsPrivate shares transactionsValuations, pricing and market trendsSelling in the private marketFAQsGlossaryCompany page and tradesProof of ownershipBid and ask submissionsForge fund offeringsInsights About UsLeadershipInvestor RelationsPeople & CultureCareers About
Log InSign Up
Who We Serve
What We Do
Insights
About
Who We Serve
Individual Investors
Institutional Investors
What We Do
Trading
Individual Investing
Institutional Trading
Data
Liquidity Programs
Retirement
Self-Directed IRA
Insights
Reports and highlights
News and trends
Private market education
Tips and tutorials
About
Log In
Sign Up
Secondary marketplace / Explore private companies / H1 IPO
H1

H1 IPO

$773MM
Series C Valuation, Jun 2022
Buy And Sell H1 StockLearn More About H1 StockAdd To Watchlist
Register for details
For more details on financing and valuation for H1, register or log in.
Please provide a valid email address.
By registering, you agree to Forge’s Terms of Use. Already registered? Log In

H1 IPO date and status

2019
Founded
IPO Mentioned
Confidential Filing
S-1 Filed
IPO

Company details

H1 is a health technology platform that aims to empower stakeholders at healthcare and life science companies to make smarter decisions using data. With a mission to connect doctors to the most relevant research information, the company offers tools like the AI-powered medical affairs and MSL platform, an investigative trial landscape, and provider data management for healthcare. H1 was founded in 2017 by Ariel Katz and Ian Sax and is headquartered in New York, NY.
h1.co
Sector
Healthcare
Subsector
Digital Health
Founded
2019
Headquarters
New York, NY, United States
Forge Price 1
Price not yet available
Market Activity 2
Limited
Last Matched Price
Get Full Access
Post-Money Valuation 3
$773MM
Total Funding
$194.74MM
Last Funding Round
Series C

Learn more about H1

To invest in H1 pre-IPO

Can you invest in H1 pre-IPO?

H1 is privately held and not traded on public markets, so pre-IPO investments are available only to accredited investors.

If you’re already accredited and have completed Forge’s verification, you can visit our marketplace to review and invest in private companies ahead of an IPO.

If you haven’t yet completed your accredited investor verification with Forge, you can start that process now to unlock access to new private-company offerings.

For more on who qualifies—and how to get verified—see our blog “Accredited investors, qualified clients and qualified purchasers: Who can invest?”

Can you sell shares of H1 before it goes public?

Yes, subject to any contractual or corporate transfer restrictions, it is possible to list your shares to sell while H1 is still private. If you’re considering selling, you can register today for free to get started. Once registered, you can evaluate pricing insights and market activity to inform your decision, then post your shares for sale and set the terms, like quantity and price—all directly through our platform.

If you’d like additional guidance at any point, Forge private market specialists are available to help. For a step-by-step overview, check out our seller’s guide.

What is the pre-IPO value of my H1 shares?

To explore the value of your H1 shares, create a free account to access Forge’s marketplace. Once inside, you’ll find several pricing insights to help guide your decision—these include historical transaction data, a live order book showing current buy and sell interest, and Forge Price™, a derived, indicative price based on recent transactions, investor activity, and other relevant market data.

These insights can help you determine a price you’re comfortable with if you choose to sell your shares. If you’d like additional guidance along the way, Forge private market specialists are available to help. You can also review our seller’s guide for a step-by-step overview.

Is H1 a publicly traded company?

H1 is a private company and not publicly traded.

If you’re interested in buying or selling shares in private companies, you can register with Forge today for free to explore available opportunities. Once registered, you’ll gain access to our marketplace, where you can view active buy and sell interest, evaluate pricing signals and take action directly through the platform.

To learn more about H1 potential IPO

Will H1 go IPO?

H1 has not yet filed for an IPO. However, it’s important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2025.

What is H1’s IPO price?

The H1 IPO price does not exist at this time, as H1 is still a private company and has not yet conducted an IPO. To explore secondary market data and access private market pricing details and data that may be related to H1, register for Forge today.

When was H1 founded?

H1 was founded in 2019.

What is H1 funding to date?

H1 has raised $194.74MM to date.

H1 pre-IPO valuation and funding rounds

Funding history chart
Funding round and deals details
Funding Date Round Amount Raised Price per Share Post-Money Valuation 3 Key Investors
06/09/2022 Series C $123MM $23.96 $773MM Altimeter Capital, Flex Capital, Goldman Sachs, Ivp, Leadedge Capital, Lux Capital, Menlo Ventures, Transformation Capital
Price per Share
$ xx.xx
Shares Outstanding
5,134,486
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Altimeter Capital, Flex Capital, Goldman Sachs, Ivp, Leadedge Capital, Lux Capital, Menlo Ventures, Transformation Capital
12/17/2020 Series B-1 $57.85MM $9.02 $247.41MM Drx Capital, Ivp, Leadedge Capital, Lux Capital, Menlo Ventures, Transformation Capital, Y Combinator
Price per Share
$ xx.xx
Shares Outstanding
6,412,544
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Drx Capital, Ivp, Leadedge Capital, Lux Capital, Menlo Ventures, Transformation Capital, Y Combinator
12/17/2020 Series B-2 $169,623.38 $3.16 $247.41MM Drx Capital, Ivp, Leadedge Capital, Lux Capital, Menlo Ventures, Transformation Capital, Y Combinator
Price per Share
$ xx.xx
Shares Outstanding
53,672
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Drx Capital, Ivp, Leadedge Capital, Lux Capital, Menlo Ventures, Transformation Capital, Y Combinator
04/22/2020 Series A-1 $12.98MM $2.36 $35.49MM Clearpoint Investment Partners, Drx Capital, Liquid 2 Ventures, Menlo Ventures, Underscore Vc, Y Combinator
Price per Share
$ xx.xx
Shares Outstanding
5,493,762
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Clearpoint Investment Partners, Drx Capital, Liquid 2 Ventures, Menlo Ventures, Underscore Vc, Y Combinator
04/22/2020 Series A-2 $585,004.00 $1.89 $35.49MM Clearpoint Investment Partners, Drx Capital, Liquid 2 Ventures, Menlo Ventures, Underscore Vc, Y Combinator
Price per Share
$ xx.xx
Shares Outstanding
309,503
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Clearpoint Investment Partners, Drx Capital, Liquid 2 Ventures, Menlo Ventures, Underscore Vc, Y Combinator
04/22/2020 Series A-3 $150,007.62 $0.16 $35.49MM Clearpoint Investment Partners, Drx Capital, Liquid 2 Ventures, Menlo Ventures, Underscore Vc, Y Combinator
Price per Share
$ xx.xx
Shares Outstanding
955,280
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Clearpoint Investment Partners, Drx Capital, Liquid 2 Ventures, Menlo Ventures, Underscore Vc, Y Combinator

H1 IPO news and media highlights

FierceBiotech 10/05/2023

Healthtech company H1 adds new AI tech to clinical trial arm

Healthcare platform company H1 is diving deeper into the power of artificial intelligence, adding GenosAI to its clinical trials arm, Trial Landscape. The new tech, unveiled Thursday, is described as incorporating a “ChatGPT-like” experience into Trial Landscape, which clients use to help establish new clinical trials. Users will be able to pose questions on the platform that GenosAI can respond to with the aid of natural language processing, such as inquiring about the best-performing trial sites or suitable locations for a particular disease area.
FierceHealthcare 11/16/2021

Health tech startup H1 banks $100M to expand its digital doctor network for pharma, medical device companies

Startup H1 developed a massive digital professional database and data analytics platform that connects healthcare professionals and life science companies. It basically serves as a LinkedIn for the pharmaceutical and biotech industries. The company just picked up $100 million in a series C round to expand its data and network as well as its product development and hiring, with a goal to make H1 the core global healthcare network for every medical professional and organization in the world, according to the company.
GlobeNewswire 08/24/2021

H1 Launches H1 Explorer, Most Comprehensive Platform of Healthcare Professionals On the Internet Where HCPs Can Now Claim and Update their Profiles

HCPs can now update profiles on largest global healthcare platform to own their narrative and get in front of key stakeholders in the medical, life...
GlobeNewswire 08/09/2021

Healthcare Data Startup H1 Acquires Carevoyance, Accelerating Entry into the Fast-Growing Medical Device Market

H1, which provides the largest global healthcare platform that connects healthcare professionals, announced today that it has acquired Portland, Oregon based Carevoyance, which offers ​​the best targeting, sales enablement, and physician segmentation platform to medical device sellers. he acquisition enables H1 to expand its presence in the medical device market, and allows Carevoyance - which will continue to operate independently, as a subsidiary of H1 - to include H1’s proprietary data in its product offering to provide more value to clients.
Browse More Insights

Private companies exploring an IPO

See which private companies are preparing for the public market. Register to get full access to the latest secondary market pricing data.

Sector: Healthcare
Subsector: Digital Health
Trade Metrics Last Funding Round
Company Forge Price Last Matched Round Post-Money Valuation 3 Price Per Share Amount Raised
Generate BiomedicinesGenerate BiomedicinesNot available$ xx.xxSeries C$2.22B$11.85$399.4MM
OriginOriginNot available$ xx.xxNot available------
Affinia TherapeuticsAffinia TherapeuticsNot available$ xx.xxSeries C$156.61MM$1.62$40MM
See Tech IPO Calendar

Private market movers

Track trading activity and investor momentum across thousands of private companies. Register to view last matched prices and additional transactional details.

Actively traded

Company Forge Price Market Activity Last Matched
Anthropic Anthropic $259.14 -$13.84 (5.07%)High $xxx.xx
OpenAI OpenAI $723.12 +$0.12 (0.02%)High $xxx.xx
SpaceX SpaceX $601.27 +$4.10 (0.69%)High $xxx.xx
Anduril Anduril $110.97 +$4.00 (3.74%)High $xxx.xx
Databricks Databricks $197.65 -$0.01 (0.01%)High $xxx.xx
See All Actively Traded Companies

Artificial Intelligence (AI)

Company Forge Price Market Activity Last Matched
Anthropic Anthropic $259.14 -$13.84 (5.07%)High $xxx.xx
OpenAI OpenAI $723.12 +$0.12 (0.02%)High $xxx.xx
Anduril Anduril $110.97 +$4.00 (3.74%)High $xxx.xx
Databricks Databricks $197.65 -$0.01 (0.01%)High $xxx.xx
Figure AI Figure AI $174.00 -$20.00 (10.31%)Limited $xxx.xx
See All AI Companies

Forge, your trusted partner for pre-IPO insights and H1 Insights data

Forge is the trusted platform for buying and selling pre-IPO shares. Investors and shareholders worldwide rely on our deep data insights, liquidity solutions, and tailored investment opportunities to navigate the private market. Register to get started.

Register

Updated on: Jul 16, 2025

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
  2. Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions on Forge.
  3. Post-Money Valuation represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
  4. Last Known Valuation represents a valuation gathered from non-COI, publicly available sources including company press releases or multiple concurring news articles.
  5. Actively traded companies are companies with a high market activity with the highest post-money valuation in the same sector.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

The news articles displayed on this page may be curated using artificial intelligence (AI) technology, which selects relevant content from a list of trusted web sources. While we strive for accuracy and reliability, the inclusion of an article does not imply endorsement or verification of its content. This communication is for informational purposes only. Investors should conduct their own research and consult a financial professional before making investment decisions.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.